Concepedia

Nicol Kurstjens

NK

Statistics

Publications

9

Citations

429

H-Index

9

Active since

1988

Affiliations

Novartis (Australia)(Current)

University of Würzburg

Baker Heart and Diabetes Institute

The University of Melbourne

The University of Western Australia

Nicol Kurstjens is an author at Novartis (Australia) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1988–2016

9

Publications

9

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial

Simon Stewart, M. Carrington, C. Swemmer et al. · BMJ · 2012 · 104 citations · Full text

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study

Jennifer Arnold, Caroline M. Markey, Nicol Kurstjens et al. · BMC Ophthalmology · 2016 · 97 citations · Full text

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial

Peter Frith, Philip J. Thompson, Rajeev Ratnavadivel et al. · Thorax · 2015 · 89 citations · Full text

A randomized, controlled trial of everolimus‐based dual immunosuppression versus standard of care in <i>de novo</i> kidney transplant recipients

Steven J. Chadban, Josette Eris, John Kanellis et al. · Transplant International · 2013 · 45 citations · Full text

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

Bruce Davidson, Nicol Kurstjens, J. Patton et al. · European Journal of Pharmacology · 1988 · 32 citations

, , +10

1–5 of 9